- Report
- January 2025
- 196 Pages
Global
From €4357EUR$4,995USD£3,797GBP
- Report
- January 2025
- 209 Pages
Global
From €4357EUR$4,995USD£3,797GBP
- Report
- January 2025
- 191 Pages
Global
From €4357EUR$4,995USD£3,797GBP
- Report
- September 2024
- 304 Pages
United States
From €2267EUR$2,599USD£1,976GBP
- Report
- June 2024
- 250 Pages
Global
From €4357EUR$4,995USD£3,797GBP
- Report
- June 2024
- 152 Pages
Global
From €4357EUR$4,995USD£3,797GBP
- Report
- May 2024
- 170 Pages
Global
From €4357EUR$4,995USD£3,797GBP
- Report
- March 2024
- 249 Pages
Global
€4357EUR$4,995USD£3,797GBP
- Report
- March 2024
- 197 Pages
Global
€4357EUR$4,995USD£3,797GBP
- Report
- November 2022
- 160 Pages
Global
€2966EUR$3,400USD£2,585GBP
- Report
- December 2025
- 150 Pages
Germany
From €3358EUR$3,850USD£2,927GBP
€4230EUR$4,850USD£3,687GBP
- Report
- December 2025
- 150 Pages
Germany
From €3358EUR$3,850USD£2,927GBP
€4230EUR$4,850USD£3,687GBP
- Report
- December 2025
- 150 Pages
Germany
From €3358EUR$3,850USD£2,927GBP
€4230EUR$4,850USD£3,687GBP
- Report
- December 2025
- 150 Pages
Germany
From €3358EUR$3,850USD£2,927GBP
€4230EUR$4,850USD£3,687GBP
- Report
- November 2025
- 150 Pages
India
From €3358EUR$3,850USD£2,927GBP
€4230EUR$4,850USD£3,687GBP
- Report
- November 2025
- 150 Pages
India
From €3358EUR$3,850USD£2,927GBP
€4230EUR$4,850USD£3,687GBP
- Report
- November 2025
- 150 Pages
India
From €3358EUR$3,850USD£2,927GBP
€4230EUR$4,850USD£3,687GBP
- Report
- November 2025
- 150 Pages
India
From €3358EUR$3,850USD£2,927GBP
€4230EUR$4,850USD£3,687GBP
- Report
- November 2025
- 150 Pages
Japan
From €3358EUR$3,850USD£2,927GBP
€4230EUR$4,850USD£3,687GBP
- Report
- November 2025
- 150 Pages
Japan
From €3358EUR$3,850USD£2,927GBP
€4230EUR$4,850USD£3,687GBP

The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders.
Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively.
Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more